Monthly
US$200
Billed every month
Metformin Hydrochloride Tablets(盐酸二甲双胍片)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 2 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders50View records ↓
Under-review filings4View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers106View records ↓
API companies with A status40View records ↓
Chemical-drug catalogue
Loaded records: 50 holders; 39 in the quality-and-efficacy consistency-evaluation category, and 10 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 新石阳光药业（河北）有限公司 | 新石阳光药业（河北）有限公司 | 国药准字H20265701 | 2026/08/25 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 新石阳光药业（河北）有限公司 | 新石阳光药业（河北）有限公司 | 国药准字H20265700 | 2026/08/25 | 0.85g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20264165 | 2026/04/29 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20264164 | 2026/04/29 | 0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 吉林吉春制药股份有限公司 | 吉林吉春制药股份有限公司 | 国药准字H20258271 | 2025/12/08 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 吉林吉春制药股份有限公司 | 吉林吉春制药股份有限公司 | 国药准字H20258272 | 2025/12/08 | 0.85g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 重庆吉斯瑞制药有限责任公司 | 重庆药友制药有限责任公司 | 国药准字H20253663 | 2025/03/18 | 0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 赤峰维康生化制药有限公司 | 赤峰维康生化制药有限公司 | 国药准字H20253297 | 2025/01/24 | 0.85g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 丹东医创药业有限责任公司 | 丹东医创药业有限责任公司 | 国药准字H21022377 | 2024/04/08 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 北京中惠药业有限公司 | 北京中惠药业有限公司 | 国药准字H20205046 | 2023/10/30 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 浙江京新药业股份有限公司 | 浙江京新药业股份有限公司 | 国药准字H20234052 | 2023/08/22 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京市永康药业有限公司 | 北京市永康药业有限公司 | 国药准字H11020596 | 2022/09/27 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 盖天力医药控股集团华东药业有限公司 | 盖天力医药控股集团华东药业有限公司 | 国药准字H20223665 | 2022/09/14 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 盖天力医药控股集团华东药业有限公司 | 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 2022/06/30 | 0.25g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 天津太平洋制药有限公司 | 天津太平洋制药有限公司 | 国药准字H12020797 | 2022/06/27 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 吉林万通药业集团梅河药业股份有限公司 | 吉林万通药业集团梅河药业股份有限公司 | 国药准字H22023684 | 2021/12/13 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 澳大利亚艾华大药厂 | 澳大利亚艾华大药厂 | H20140534 | 2021/08/19 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 重庆希尔安药业有限公司 | 重庆希尔安药业有限公司 | 国药准字H20174055 | 2021/07/19 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 寿光富康制药有限公司 | 寿光富康制药有限公司 | 国药准字H20213504 | 2021/06/16 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 天津市康瑞药业有限公司 | 天津市康瑞药业有限公司 | 国药准字H19983087 | 2021/04/06 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江苏天士力帝益药业有限公司 | 江苏天士力帝益药业有限公司 | 国药准字H32020197 | 2021/01/05 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 悦康药业集团股份有限公司 | 悦康药业集团股份有限公司 | 国药准字H20184075 | 2020/12/23 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 浙江亚太药业股份有限公司 | 浙江亚太药业股份有限公司 | 国药准字H33020106 | 2020/12/23 | 0.25g，以C4H11N5HCl计 | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 上海上药信谊药厂有限公司 | 上海上药信谊药厂有限公司 | 国药准字H31022081 | 2020/12/16 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 浙江国光生物制药有限公司 | 浙江国光生物制药有限公司 | 国药准字H33020526 | 2020/12/15 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 东莞市阳之康医药有限责任公司 | 广东东阳光药业有限公司 | 国药准字H20203659 | 2020/12/08 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 东莞市阳之康医药有限责任公司 | 广东东阳光药业有限公司 | 国药准字H20203660 | 2020/12/08 | 0.85g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京中新药业股份有限公司 | 北京中新药业股份有限公司 | 国药准字H13020586 | 2020/12/03 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山西振东安特生物制药有限公司 | 山西振东安特生物制药有限公司 | 国药准字H14020843 | 2020/10/19 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 广东赛康制药厂有限公司 | 广东赛康制药厂有限公司 | 国药准字H20203369 | 2020/07/29 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东赛康制药厂有限公司 | 广东赛康制药厂有限公司 | 国药准字H20203366 | 2020/07/29 | 0.85g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| — | 哈尔滨珍宝制药有限公司 | 国药准字H19999107 | 2020/04/15 | 0.25g | Not stated by source | CDE |
| — | 昆山培力药品有限公司 | 国药准字H32021473 | 2020/03/25 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 迪沙药业集团有限公司 | 国药准字H20103615 | 2020/03/25 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 天津中新药业集团股份有限公司新新制药厂 | 国药准字H12020587 | 2020/03/03 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 上海上药信谊药厂有限公司 | 国药准字H20123035 | 2020/03/03 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 深圳市中联制药有限公司 | 国药准字H20023251 | 2020/03/03 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 苏州东瑞制药有限公司 | 国药准字H20023161 | 2020/02/27 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 上海衡山药业有限公司 | 国药准字H31021359 | 2020/02/19 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 江苏苏中药业集团股份有限公司 | 国药准字H32021625 | 2020/01/15 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 华北制药股份有限公司 | 国药准字H20113492 | 2019/12/27 | 0.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 吉林金恒制药股份有限公司 | 国药准字H22023147 | 2019/12/26 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 北京利龄恒泰药业有限公司 | 国药准字H11020957 | 2019/12/10 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 郑州泰丰制药有限公司 | 国药准字H20174087 | 2019/11/15 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 重庆康刻尔制药有限公司 | 国药准字H20033597 | 2019/11/15 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 深圳海王药业有限公司 | 国药准字H20023543 | 2019/11/15 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 重庆科瑞制药（集团）有限公司 | 国药准字H50020322 | 2019/11/14 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 石家庄以岭药业股份有限公司 | 国药准字H20054790 | 2019/11/11 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 哈药集团制药六厂 | 国药准字H20184130 | 2019/10/21 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 蓬莱诺康药业有限公司 | 国药准字H37020550 | 2019/09/10 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 河北天成药业股份有限公司 | 河北天成药业股份有限公司 | 国药准字H13021647 | 2019/07/19 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 深圳市中联制药有限公司 | 国药准字H44024853 | 2019/07/02 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 上海信谊天平药业有限公司 | 国药准字H31020246 | 2019/04/15 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 北京京丰制药集团有限公司 | 国药准字H11021518 | 2019/04/15 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 贵州天安药业股份有限公司 | 国药准字H52020469 | 2019/02/02 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 广东华南药业集团有限公司 | 国药准字H44020775 | 2018/10/27 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 北京四环制药有限公司 | 北京四环制药有限公司 | 国药准字H11020127 | 2018/09/26 | 0.25g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 石药集团欧意药业有限公司 | 国药准字H20183290 | 2018/07/12 | 0.85g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| — | 石药集团欧意药业有限公司 | 国药准字H20183289 | 2018/07/12 | 0.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 106 distinct approval numbers and 94 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 石家庄四药有限公司 | 国药准字H20264164 | 0.25g | Category A (甲) | XA10BAE021A001010102763 | NHSA |
| 石家庄四药有限公司 | 国药准字H20264165 | 0.5g | Category A (甲) | XA10BAE021A001020102763 | NHSA |
| 赤峰维康生化制药有限公司 | 国药准字H20253297 | 0.85g | Category A (甲) | XA10BAE021A001010103870 | NHSA |
| 重庆吉斯瑞制药有限责任公司 | 国药准字H20253663 | 0.25g | Category A (甲) | XA10BAE021A001010182974 | NHSA |
| 赤峰维康生化制药有限公司 | 国药准字H20253297 | 0.85g | Category A (甲) | XA10BAE021A001010203870 | NHSA |
| 重庆吉斯瑞制药有限责任公司 | 国药准字H20253663 | 0.25g | Category A (甲) | XA10BAE021A001010282974 | NHSA |
| 赤峰维康生化制药有限公司 | 国药准字H20253297 | 0.85g | Category A (甲) | XA10BAE021A001010303870 | NHSA |
| 重庆吉斯瑞制药有限责任公司 | 国药准字H20253663 | 0.25g | Category A (甲) | XA10BAE021A001010382974 | NHSA |
| 赤峰维康生化制药有限公司 | 国药准字H20253297 | 0.85g | Category A (甲) | XA10BAE021A001010403870 | NHSA |
| 赤峰维康生化制药有限公司 | 国药准字H20253297 | 0.85g | Category A (甲) | XA10BAE021A001010503870 | NHSA |
| 赤峰维康生化制药有限公司 | 国药准字H20253297 | 0.85g | Category A (甲) | XA10BAE021A001010603870 | NHSA |
| 北京京丰制药集团有限公司 | 国药准字H11021518 | 0.25g | Category A (甲) | XA10BAE021A001010100062 | NHSA |
| 北京中惠药业有限公司 | 国药准字H19983069 | 0.25g | Category A (甲) | XA10BAE021A001010100221 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20184075 | 0.25g | Category A (甲) | XA10BAE021A001010100239 | NHSA |
| 广东华南药业集团有限公司 | 国药准字H44020775 | 0.25g | Category A (甲) | XA10BAE021A001010100290 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H44023514 | 0.25g | Category A (甲) | XA10BAE021A001010100377 | NHSA |
| 广州柏赛罗药业有限公司 | 国药准字H20033077 | 0.25g | Category A (甲) | XA10BAE021A001010100387 | NHSA |
| 广州白云山中一药业有限公司 | 国药准字H20063661 | 0.25g | Category A (甲) | XA10BAE021A001010100428 | NHSA |
| 丽珠集团丽珠制药厂 | 国药准字H44020837 | 0.25g | Category A (甲) | XA10BAE021A001010100453 | NHSA |
| 深圳海王药业有限公司 | 国药准字H20023543 | 0.25g | Category A (甲) | XA10BAE021A001010100503 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H44024853 | 0.25g | Category A (甲) | XA10BAE021A001010100543 | NHSA |
| 上海衡山药业有限公司 | 国药准字H31021359 | 0.25g | Category A (甲) | XA10BAE021A001010100676 | NHSA |
| 上海信谊天平药业有限公司 | 国药准字H31020246 | 0.25g | Category A (甲) | XA10BAE021A001010100680 | NHSA |
| 上海上药信谊药厂有限公司 | 国药准字H31022081 | 0.25g | Category A (甲) | XA10BAE021A001010100818 | NHSA |
| 默克制药(江苏)有限公司 | 国药准字H20023370 | 0.5g | Category A (甲) | XA10BAE021A001010100842 | NHSA |
| 秦皇岛爱晖药业有限公司 | 国药准字H12020212 | 0.25g | Category A (甲) | XA10BAE021A001010100858 | NHSA |
| 山德士(中国)制药有限公司 | 国药准字H20013054 | 0.25g | Category A (甲) | XA10BAE021A001010100863 | NHSA |
| 天津市康瑞药业有限公司 | 国药准字H19983087 | 0.25g | Category A (甲) | XA10BAE021A001010100914 | NHSA |
| 天津太平洋制药有限公司 | 国药准字H12020797 | 0.25g | Category A (甲) | XA10BAE021A001010100931 | NHSA |
| 津药达仁堂集团股份有限公司新新制药厂 | 国药准字H12020587 | 0.25g | Category A (甲) | XA10BAE021A001010100964 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20033597 | 0.25g | Category A (甲) | XA10BAE021A001010101014 | NHSA |
| 重庆科瑞制药(集团)有限公司 | 国药准字H50020322 | 0.25g | Category A (甲) | XA10BAE021A001010101016 | NHSA |
| 重庆通和药业有限公司 | 国药准字H20003895 | 0.25g | Category A (甲) | XA10BAE021A001010101056 | NHSA |
| 重庆希尔安药业有限公司 | 国药准字H20174055 | 0.25g | Category A (甲) | XA10BAE021A001010101061 | NHSA |
| 丹东医创药业有限责任公司 | 国药准字H21022377 | 0.25g | Category A (甲) | XA10BAE021A001010101157 | NHSA |
| 常州制药厂有限公司 | 国药准字H20054786 | 0.25g(以盐酸二甲双胍计) | Category A (甲) | XA10BAE021A001010101397 | NHSA |
| 江苏恩华药业股份有限公司 | 国药准字H32020210 | 0.25g | Category A (甲) | XA10BAE021A001010101436 | NHSA |
| 丰华生物制药(江苏)有限责任公司 | 国药准字H20033458 | 0.25g | Category A (甲) | XA10BAE021A001010101437 | NHSA |
| 江苏鹏鹞药业有限公司 | 国药准字H20055785 | 0.25g | Category A (甲) | XA10BAE021A001010101470 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H32021625 | 0.25g | Category A (甲) | XA10BAE021A001010101493 | NHSA |
| 江苏天士力帝益药业有限公司 | 国药准字H32020197 | 0.25g | Category A (甲) | XA10BAE021A001010101500 | NHSA |
| 昆山培力药品有限公司 | 国药准字H32021474 | 0.25g | Category A (甲) | XA10BAE021A001010101534 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20023161 | 0.25g | Category A (甲) | XA10BAE021A001010101650 | NHSA |
| 苏州爱美津制药有限公司 | 国药准字H20033545 | 0.25g | Category A (甲) | XA10BAE021A001010101667 | NHSA |
| 安康正大制药有限公司 | 国药准字H61020603 | 0.25g | Category A (甲) | XA10BAE021A001010102329 | NHSA |
| 金花企业(集团)股份有限公司西安金花制药厂 | 国药准字H61022108 | 0.25g | Category A (甲) | XA10BAE021A001010102347 | NHSA |
| 河北长天药业有限公司 | 国药准字H13020559 | 0.25g | Category A (甲) | XA10BAE021A001010102596 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010102662 | NHSA |
| 华北制药股份有限公司 | 国药准字H20113492 | 0.5g | Category A (甲) | XA10BAE021A001010102690 | NHSA |
| 华北制药股份有限公司 | 国药准字H13020734 | 0.25g | Category A (甲) | XA10BAE021A001010102699 | NHSA |
| 石家庄以岭药业股份有限公司 | 国药准字H20054790 | 0.25g | Category A (甲) | XA10BAE021A001010102767 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20183289 | 0.5g | Category A (甲) | XA10BAE021A001010102770 | NHSA |
| 北京海王中新药业股份有限公司 | 国药准字H13020586 | 0.25g | Category A (甲) | XA10BAE021A001010102831 | NHSA |
| 山西双雁药业有限公司 | 国药准字H14022660 | 0.25g | Category A (甲) | XA10BAE021A001010102851 | NHSA |
| 山西汾河制药有限公司 | 国药准字H14023737 | 0.25g | Category A (甲) | XA10BAE021A001010102951 | NHSA |
| 白云山汤阴东泰药业有限责任公司 | 国药准字H41020541 | 0.25g | Category A (甲) | XA10BAE021A001010103004 | NHSA |
| 白云山东泰商丘药业有限公司 | 国药准字H20043292 | 0.25g | Category A (甲) | XA10BAE021A001010103081 | NHSA |
| 上海寿如松药业泌阳制药有限公司 | 国药准字H41020643 | 0.25g | Category A (甲) | XA10BAE021A001010103165 | NHSA |
| 开封康诺药业有限公司 | 国药准字H19994078 | 0.25g | Category A (甲) | XA10BAE021A001010103244 | NHSA |
| 吉林道君药业股份有限公司 | 国药准字H22021585 | 0.25g | Category A (甲) | XA10BAE021A001010103366 | NHSA |
| 吉林金恒制药股份有限公司 | 国药准字H22023147 | 0.25g | Category A (甲) | XA10BAE021A001010103372 | NHSA |
| 吉林吉春制药股份有限公司 | 国药准字H22021486 | 0.25g | Category A (甲) | XA10BAE021A001010103374 | NHSA |
| 吉林万通药业集团梅河药业股份有限公司 | 国药准字H22023684 | 0.25g | Category A (甲) | XA10BAE021A001010103498 | NHSA |
| 辽源市迪康药业有限责任公司 | 国药准字H22023654 | 0.25g | Category A (甲) | XA10BAE021A001010103506 | NHSA |
| 哈尔滨珍宝制药有限公司 | 国药准字H19999107 | 0.25g | Category A (甲) | XA10BAE021A001010103677 | NHSA |
| 哈药集团制药六厂 | 国药准字H20184130 | 0.25g | Category A (甲) | XA10BAE021A001010103710 | NHSA |
| 迪沙药业集团有限公司 | 国药准字H20103615 | 0.25g | Category A (甲) | XA10BAE021A001010103944 | NHSA |
| 山东明仁福瑞达制药股份有限公司 | 国药准字H37020003 | 0.25g | Category A (甲) | XA10BAE021A001010103965 | NHSA |
| 济南恒基制药有限公司 | 国药准字H37021405 | 0.25g | Category A (甲) | XA10BAE021A001010103968 | NHSA |
| 远大生命科学(山东)有限公司 | 国药准字H37020550 | 0.25g | Category A (甲) | XA10BAE021A001010104017 | NHSA |
| 齐鲁制药有限公司 | 国药准字H37020561 | 0.25g | Category A (甲) | XA10BAE021A001010104021 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H10983056 | 0.25g | Category A (甲) | XA10BAE021A001010104105 | NHSA |
| 沂南力诺制药有限责任公司 | 国药准字H37023557 | 0.25g | Category A (甲) | XA10BAE021A001010104120 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20213504 | 0.5g | Category A (甲) | XA10BAE021A001010104206 | NHSA |
| 浙江惠松制药有限公司 | 国药准字H33021614 | 0.25g | Category A (甲) | XA10BAE021A001010104486 | NHSA |
| 台州南峰药业有限公司 | 国药准字H33021126 | 0.25g | Category A (甲) | XA10BAE021A001010104579 | NHSA |
| 浙江国光生物制药股份有限公司 | 国药准字H33020526 | 0.25g | Category A (甲) | XA10BAE021A001010104633 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20234052 | 0.5g | Category A (甲) | XA10BAE021A001010104658 | NHSA |
| 浙江普洛康裕制药有限公司 | 国药准字H33021161 | 0.25g | Category A (甲) | XA10BAE021A001010104685 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H33020106 | 0.25g | Category A (甲) | XA10BAE021A001010104744 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H35020664 | 0.25g | Category A (甲) | XA10BAE021A001010104864 | NHSA |
| 湖南湘雅制药有限公司 | 国药准字H43020884 | 0.25g | Category A (甲) | XA10BAE021A001010104987 | NHSA |
| 湖南明瑞制药股份有限公司 | 国药准字H43020098 | 0.25g | Category A (甲) | XA10BAE021A001010105001 | NHSA |
| 江西汇仁药业股份有限公司 | 国药准字H20065984 | 0.25g | Category A (甲) | XA10BAE021A001010105297 | NHSA |
| 广东东阳光药业股份有限公司 | 国药准字H20203659 | 0.5g | Category A (甲) | XA10BAE021A001010106988 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010107011 | NHSA |
| Alphapharm Pty Limited | 国药准字HJ20140534 | 0.5g | Category A (甲) | XA10BAE021A001010178209 | NHSA |
| MERCK SANTE s.a.s. | 国药准字HJ20200039 | 0.85g | Category A (甲) | XA10BAE021A001010178638 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203369 | 0.5g | Category A (甲) | XA10BAE021A001010180463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010180625 | NHSA |
| 北京京丰制药集团有限公司 | 国药准字H11021518 | 0.25g | Category A (甲) | XA10BAE021A001010200062 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20184075 | 0.25g | Category A (甲) | XA10BAE021A001010200239 | NHSA |
| 广东华南药业集团有限公司 | 国药准字H44020775 | 0.25g | Category A (甲) | XA10BAE021A001010200290 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H44023514 | 0.25g | Category A (甲) | XA10BAE021A001010200377 | NHSA |
| 深圳海王药业有限公司 | 国药准字H20023543 | 0.25g | Category A (甲) | XA10BAE021A001010200503 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H44024853 | 0.25g | Category A (甲) | XA10BAE021A001010200543 | NHSA |
| 上海衡山药业有限公司 | 国药准字H31021359 | 0.25g | Category A (甲) | XA10BAE021A001010200676 | NHSA |
| 上海信谊天平药业有限公司 | 国药准字H31020246 | 0.25g | Category A (甲) | XA10BAE021A001010200680 | NHSA |
| 上海上药信谊药厂有限公司 | 国药准字H31022081 | 0.25g | Category A (甲) | XA10BAE021A001010200818 | NHSA |
| 默克制药(江苏)有限公司 | 国药准字H20023370 | 0.5g | Category A (甲) | XA10BAE021A001010200842 | NHSA |
| 秦皇岛爱晖药业有限公司 | 国药准字H12020212 | 0.25g | Category A (甲) | XA10BAE021A001010200858 | NHSA |
| 天津市康瑞药业有限公司 | 国药准字H19983087 | 0.25g | Category A (甲) | XA10BAE021A001010200914 | NHSA |
| 天津太平洋制药有限公司 | 国药准字H12020797 | 0.25g | Category A (甲) | XA10BAE021A001010200931 | NHSA |
| 津药达仁堂集团股份有限公司新新制药厂 | 国药准字H12020587 | 0.25g | Category A (甲) | XA10BAE021A001010200964 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20033597 | 0.25g | Category A (甲) | XA10BAE021A001010201014 | NHSA |
| 重庆科瑞制药(集团)有限公司 | 国药准字H50020322 | 0.25g | Category A (甲) | XA10BAE021A001010201016 | NHSA |
| 丹东医创药业有限责任公司 | 国药准字H21022377 | 0.25g | Category A (甲) | XA10BAE021A001010201157 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H21024375 | 0.25g | Category A (甲) | XA10BAE021A001010201245 | NHSA |
| 丰华生物制药(江苏)有限责任公司 | 国药准字H20033458 | 0.25g | Category A (甲) | XA10BAE021A001010201437 | NHSA |
| 江苏鹏鹞药业有限公司 | 国药准字H20055785 | 0.25g | Category A (甲) | XA10BAE021A001010201470 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H32021625 | 0.25g | Category A (甲) | XA10BAE021A001010201493 | NHSA |
| 江苏天士力帝益药业有限公司 | 国药准字H32020197 | 0.25g | Category A (甲) | XA10BAE021A001010201500 | NHSA |
| 苏州东瑞制药有限公司 | 国药准字H20023161 | 0.25g | Category A (甲) | XA10BAE021A001010201650 | NHSA |
| 安康正大制药有限公司 | 国药准字H61020603 | 0.25g | Category A (甲) | XA10BAE021A001010202329 | NHSA |
| 金花企业(集团)股份有限公司西安金花制药厂 | 国药准字H61022108 | 0.25g | Category A (甲) | XA10BAE021A001010202347 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010202662 | NHSA |
| 华北制药股份有限公司 | 国药准字H20113492 | 0.5g | Category A (甲) | XA10BAE021A001010202690 | NHSA |
| 华北制药股份有限公司 | 国药准字H13020734 | 0.25g | Category A (甲) | XA10BAE021A001010202699 | NHSA |
| 石家庄以岭药业股份有限公司 | 国药准字H20054790 | 0.25g | Category A (甲) | XA10BAE021A001010202767 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20183289 | 0.5g | Category A (甲) | XA10BAE021A001010202770 | NHSA |
| 北京海王中新药业股份有限公司 | 国药准字H13020586 | 0.25g | Category A (甲) | XA10BAE021A001010202831 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H14020843 | 0.25g | Category A (甲) | XA10BAE021A001010202868 | NHSA |
| 山西汾河制药有限公司 | 国药准字H14023737 | 0.25g | Category A (甲) | XA10BAE021A001010202951 | NHSA |
| 白云山汤阴东泰药业有限责任公司 | 国药准字H41020541 | 0.25g | Category A (甲) | XA10BAE021A001010203004 | NHSA |
| 白云山东泰商丘药业有限公司 | 国药准字H20043292 | 0.25g | Category A (甲) | XA10BAE021A001010203081 | NHSA |
| 上海寿如松药业泌阳制药有限公司 | 国药准字H41020643 | 0.25g | Category A (甲) | XA10BAE021A001010203165 | NHSA |
| 开封康诺药业有限公司 | 国药准字H19994078 | 0.25g | Category A (甲) | XA10BAE021A001010203244 | NHSA |
| 辽源市迪康药业有限责任公司 | 国药准字H22023654 | 0.25g | Category A (甲) | XA10BAE021A001010203506 | NHSA |
| 哈尔滨珍宝制药有限公司 | 国药准字H19999107 | 0.25g | Category A (甲) | XA10BAE021A001010203677 | NHSA |
| 迪沙药业集团有限公司 | 国药准字H20103615 | 0.25g | Category A (甲) | XA10BAE021A001010203944 | NHSA |
| 远大生命科学(山东)有限公司 | 国药准字H37020550 | 0.25g | Category A (甲) | XA10BAE021A001010204017 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H10983056 | 0.25g | Category A (甲) | XA10BAE021A001010204105 | NHSA |
| 沂南力诺制药有限责任公司 | 国药准字H37023557 | 0.25g | Category A (甲) | XA10BAE021A001010204120 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20213504 | 0.5g | Category A (甲) | XA10BAE021A001010204206 | NHSA |
| 浙江国光生物制药股份有限公司 | 国药准字H33020526 | 0.25g | Category A (甲) | XA10BAE021A001010204633 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20234052 | 0.5g | Category A (甲) | XA10BAE021A001010204658 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H33020106 | 0.25g | Category A (甲) | XA10BAE021A001010204744 | NHSA |
| 湖南湘雅制药有限公司 | 国药准字H43020884 | 0.25g | Category A (甲) | XA10BAE021A001010204987 | NHSA |
| 湖南明瑞制药股份有限公司 | 国药准字H43020098 | 0.25g | Category A (甲) | XA10BAE021A001010205001 | NHSA |
| 广东东阳光药业股份有限公司 | 国药准字H20203659 | 0.5g | Category A (甲) | XA10BAE021A001010206988 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010207011 | NHSA |
| MERCK SANTE s.a.s. | 国药准字HJ20200039 | 0.85g | Category A (甲) | XA10BAE021A001010278638 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203369 | 0.5g | Category A (甲) | XA10BAE021A001010280463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010280625 | NHSA |
| 广东华南药业集团有限公司 | 国药准字H44020775 | 0.25g | Category A (甲) | XA10BAE021A001010300290 | NHSA |
| 深圳海王药业有限公司 | 国药准字H20023543 | 0.25g | Category A (甲) | XA10BAE021A001010300503 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H44024853 | 0.25g | Category A (甲) | XA10BAE021A001010300543 | NHSA |
| 上海衡山药业有限公司 | 国药准字H31021359 | 0.25g | Category A (甲) | XA10BAE021A001010300676 | NHSA |
| 上海信谊天平药业有限公司 | 国药准字H31020246 | 0.25g | Category A (甲) | XA10BAE021A001010300680 | NHSA |
| 上海上药信谊药厂有限公司 | 国药准字H31021130 | 0.25g | Category A (甲) | XA10BAE021A001010300818 | NHSA |
| 天津市康瑞药业有限公司 | 国药准字H19983087 | 0.25g | Category A (甲) | XA10BAE021A001010300914 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20033597 | 0.25g | Category A (甲) | XA10BAE021A001010301014 | NHSA |
| 重庆科瑞制药(集团)有限公司 | 国药准字H50020322 | 0.25g | Category A (甲) | XA10BAE021A001010301016 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H21024375 | 0.25g | Category A (甲) | XA10BAE021A001010301245 | NHSA |
| 江苏鹏鹞药业有限公司 | 国药准字H20055785 | 0.25g | Category A (甲) | XA10BAE021A001010301470 | NHSA |
| 安康正大制药有限公司 | 国药准字H61020603 | 0.25g | Category A (甲) | XA10BAE021A001010302329 | NHSA |
| 金花企业(集团)股份有限公司西安金花制药厂 | 国药准字H61022108 | 0.25g | Category A (甲) | XA10BAE021A001010302347 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010302662 | NHSA |
| 华北制药股份有限公司 | 国药准字H20113492 | 0.5g | Category A (甲) | XA10BAE021A001010302690 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20183289 | 0.5g | Category A (甲) | XA10BAE021A001010302770 | NHSA |
| 北京海王中新药业股份有限公司 | 国药准字H13020586 | 0.25g | Category A (甲) | XA10BAE021A001010302831 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H14020843 | 0.25g | Category A (甲) | XA10BAE021A001010302868 | NHSA |
| 山西汾河制药有限公司 | 国药准字H14023737 | 0.25g | Category A (甲) | XA10BAE021A001010302951 | NHSA |
| 白云山东泰商丘药业有限公司 | 国药准字H20043292 | 0.25g | Category A (甲) | XA10BAE021A001010303081 | NHSA |
| 哈尔滨珍宝制药有限公司 | 国药准字H19999107 | 0.25g | Category A (甲) | XA10BAE021A001010303677 | NHSA |
| 北京京丰制药(山东)有限公司 | 国药准字H10983056 | 0.25g | Category A (甲) | XA10BAE021A001010304105 | NHSA |
| 沂南力诺制药有限责任公司 | 国药准字H37023557 | 0.25g | Category A (甲) | XA10BAE021A001010304120 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20213504 | 0.5g | Category A (甲) | XA10BAE021A001010304206 | NHSA |
| 浙江国光生物制药股份有限公司 | 国药准字H33020526 | 0.25g | Category A (甲) | XA10BAE021A001010304633 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H33020106 | 0.25g | Category A (甲) | XA10BAE021A001010304744 | NHSA |
| 湖南湘雅制药有限公司 | 国药准字H43020884 | 0.25g | Category A (甲) | XA10BAE021A001010304987 | NHSA |
| 湖南明瑞制药股份有限公司 | 国药准字H43020098 | 0.25g | Category A (甲) | XA10BAE021A001010305001 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010307011 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203369 | 0.5g | Category A (甲) | XA10BAE021A001010380463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010380625 | NHSA |
| 北京京丰制药集团有限公司 | 国药准字H11021518 | 0.25g | Category A (甲) | XA10BAE021A001010400062 | NHSA |
| 广东华南药业集团有限公司 | 国药准字H44020775 | 0.25g | Category A (甲) | XA10BAE021A001010400290 | NHSA |
| 深圳海王药业有限公司 | 国药准字H20023543 | 0.25g | Category A (甲) | XA10BAE021A001010400503 | NHSA |
| 深圳市中联制药有限公司 | 国药准字H44024853 | 0.25g | Category A (甲) | XA10BAE021A001010400543 | NHSA |
| 上海上药信谊药厂有限公司 | 国药准字H31021130 | 0.25g | Category A (甲) | XA10BAE021A001010400818 | NHSA |
| 重庆康刻尔制药股份有限公司 | 国药准字H20033597 | 0.25g | Category A (甲) | XA10BAE021A001010401014 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H21024375 | 0.25g | Category A (甲) | XA10BAE021A001010401245 | NHSA |
| 江苏鹏鹞药业有限公司 | 国药准字H20055785 | 0.25g | Category A (甲) | XA10BAE021A001010401470 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010402662 | NHSA |
| 华北制药股份有限公司 | 国药准字H20113492 | 0.5g | Category A (甲) | XA10BAE021A001010402690 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H14020843 | 0.25g | Category A (甲) | XA10BAE021A001010402868 | NHSA |
| 山西汾河制药有限公司 | 国药准字H14023737 | 0.25g | Category A (甲) | XA10BAE021A001010402951 | NHSA |
| 白云山东泰商丘药业有限公司 | 国药准字H20043292 | 0.25g | Category A (甲) | XA10BAE021A001010403081 | NHSA |
| 沂南力诺制药有限责任公司 | 国药准字H37023557 | 0.25g | Category A (甲) | XA10BAE021A001010404120 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20213504 | 0.5g | Category A (甲) | XA10BAE021A001010404206 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H33020106 | 0.25g | Category A (甲) | XA10BAE021A001010404744 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010407011 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203369 | 0.5g | Category A (甲) | XA10BAE021A001010480463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010480625 | NHSA |
| 北京京丰制药集团有限公司 | 国药准字H11021518 | 0.25g | Category A (甲) | XA10BAE021A001010500062 | NHSA |
| 深圳海王药业有限公司 | 国药准字H20023543 | 0.25g | Category A (甲) | XA10BAE021A001010500503 | NHSA |
| 郑州泰丰制药有限公司 | 国药准字H21024375 | 0.25g | Category A (甲) | XA10BAE021A001010501245 | NHSA |
| 江苏鹏鹞药业有限公司 | 国药准字H20055785 | 0.25g | Category A (甲) | XA10BAE021A001010501470 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010502662 | NHSA |
| 华北制药股份有限公司 | 国药准字H20113492 | 0.5g | Category A (甲) | XA10BAE021A001010502690 | NHSA |
| 山西振东安欣生物制药有限公司 | 国药准字H14020843 | 0.25g | Category A (甲) | XA10BAE021A001010502868 | NHSA |
| 白云山东泰商丘药业有限公司 | 国药准字H20043292 | 0.25g | Category A (甲) | XA10BAE021A001010503081 | NHSA |
| 沂南力诺制药有限责任公司 | 国药准字H37023557 | 0.25g | Category A (甲) | XA10BAE021A001010504120 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20213504 | 0.5g | Category A (甲) | XA10BAE021A001010504206 | NHSA |
| 浙江亚太药业股份有限公司 | 国药准字H33020106 | 0.25g | Category A (甲) | XA10BAE021A001010504744 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010507011 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203369 | 0.5g | Category A (甲) | XA10BAE021A001010580463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010580625 | NHSA |
| 北京京丰制药集团有限公司 | 国药准字H11021518 | 0.25g | Category A (甲) | XA10BAE021A001010600062 | NHSA |
| 深圳海王药业有限公司 | 国药准字H20023543 | 0.25g | Category A (甲) | XA10BAE021A001010600503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010602662 | NHSA |
| 白云山东泰商丘药业有限公司 | 国药准字H20043292 | 0.25g | Category A (甲) | XA10BAE021A001010603081 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010607011 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010680625 | NHSA |
| 北京京丰制药集团有限公司 | 国药准字H11021518 | 0.25g | Category A (甲) | XA10BAE021A001010700062 | NHSA |
| 深圳海王药业有限公司 | 国药准字H20023543 | 0.25g | Category A (甲) | XA10BAE021A001010700503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010702662 | NHSA |
| 白云山东泰商丘药业有限公司 | 国药准字H20043292 | 0.25g | Category A (甲) | XA10BAE021A001010703081 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010707011 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010780625 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010802662 | NHSA |
| 白云山东泰商丘药业有限公司 | 国药准字H20043292 | 0.25g | Category A (甲) | XA10BAE021A001010803081 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010807011 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010880625 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13021647 | 0.25g | Category A (甲) | XA10BAE021A001010902662 | NHSA |
| 山东普瑞曼药业有限公司 | 国药准字H20174087 | 0.25g | Category A (甲) | XA10BAE021A001010907011 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223452 | 0.25g | Category A (甲) | XA10BAE021A001010980625 | NHSA |
| 北京中惠药业有限公司 | 国药准字H20205046 | 0.5g | Category A (甲) | XA10BAE021A001020100221 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20023251 | 0.5g | Category A (甲) | XA10BAE021A001020100543 | NHSA |
| 津药达仁堂集团股份有限公司新新制药厂 | 国药准字H12020587 | 0.25g | Category A (甲) | XA10BAE021A001020100964 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H32021625 | 0.25g | Category A (甲) | XA10BAE021A001020101493 | NHSA |
| 昆山培力药品有限公司 | 国药准字H32021473 | 0.5g | Category A (甲) | XA10BAE021A001020101534 | NHSA |
| 金花企业(集团)股份有限公司西安金花制药厂 | 国药准字H61022108 | 0.25g | Category A (甲) | XA10BAE021A001020102347 | NHSA |
| 上海上药信谊药厂有限公司 | 国药准字H20123035 | 0.5g | Category A (甲) | XA10BAE021A001020102662 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20183290 | 0.85g | Category A (甲) | XA10BAE021A001020102770 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20227136 | 0.25g | Category A (甲) | XA10BAE021A001020104206 | NHSA |
| MERCK SANTE s.a.s. | 国药准字HJ20200040 | 0.5g | Category A (甲) | XA10BAE021A001020178638 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203366 | 0.85g | Category A (甲) | XA10BAE021A001020180463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223665 | 0.5g | Category A (甲) | XA10BAE021A001020180625 | NHSA |
| 北京中惠药业有限公司 | 国药准字H20205046 | 0.5g | Category A (甲) | XA10BAE021A001020200221 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20023251 | 0.5g | Category A (甲) | XA10BAE021A001020200543 | NHSA |
| 津药达仁堂集团股份有限公司新新制药厂 | 国药准字H12020587 | 0.25g | Category A (甲) | XA10BAE021A001020200964 | NHSA |
| 上海上药信谊药厂有限公司 | 国药准字H20123035 | 0.5g | Category A (甲) | XA10BAE021A001020202662 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20183290 | 0.85g | Category A (甲) | XA10BAE021A001020202770 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20227136 | 0.25g | Category A (甲) | XA10BAE021A001020204206 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203366 | 0.85g | Category A (甲) | XA10BAE021A001020280463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223665 | 0.5g | Category A (甲) | XA10BAE021A001020280625 | NHSA |
| 北京中惠药业有限公司 | 国药准字H20205046 | 0.5g | Category A (甲) | XA10BAE021A001020300221 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20023251 | 0.5g | Category A (甲) | XA10BAE021A001020300543 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20227136 | 0.25g | Category A (甲) | XA10BAE021A001020304206 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203366 | 0.85g | Category A (甲) | XA10BAE021A001020380463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223665 | 0.5g | Category A (甲) | XA10BAE021A001020380625 | NHSA |
| 北京中惠药业有限公司 | 国药准字H20205046 | 0.5g | Category A (甲) | XA10BAE021A001020400221 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20023251 | 0.5g | Category A (甲) | XA10BAE021A001020400543 | NHSA |
| 津药达仁堂集团股份有限公司新新制药厂 | 国药准字H12020587 | 0.25g | Category A (甲) | XA10BAE021A001020400964 | NHSA |
| 寿光富康制药有限公司 | 国药准字H20227136 | 0.25g | Category A (甲) | XA10BAE021A001020404206 | NHSA |
| 广东赛康制药厂有限公司 | 国药准字H20203366 | 0.85g | Category A (甲) | XA10BAE021A001020480463 | NHSA |
| 盖天力医药控股集团华东药业有限公司 | 国药准字H20223665 | 0.5g | Category A (甲) | XA10BAE021A001020480625 | NHSA |
| 北京中惠药业有限公司 | 国药准字H20205046 | 0.5g | Category A (甲) | XA10BAE021A001020500221 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20023251 | 0.5g | Category A (甲) | XA10BAE021A001020500543 | NHSA |
| 北京中惠药业有限公司 | 国药准字H20205046 | 0.5g | Category A (甲) | XA10BAE021A001020600221 | NHSA |
| 北京中惠药业有限公司 | 国药准字H20205046 | 0.5g | Category A (甲) | XA10BAE021A001020700221 | NHSA |
| 昆山培力药品有限公司 | 国药准字H32021473 | 0.5g | Category A (甲) | XA10BAE021A001030101534 | NHSA |
| 北京利龄恒泰药业有限公司 | 国药准字H11020957 | 0.25g | Category A (甲) | XA10BAE021A017010100088 | NHSA |
| 北京市永康药业有限公司 | 国药准字H11020596 | 0.25g | Category A (甲) | XA10BAE021A017010100137 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H11020541 | 0.25g | Category A (甲) | XA10BAE021A017010100144 | NHSA |
| 北京四环制药有限公司 | 国药准字H11020127 | 0.25g | Category A (甲) | XA10BAE021A017010100153 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H44023514 | 0.25g | Category A (甲) | XA10BAE021A017010100377 | NHSA |
| 成都川力制药有限公司 | 国药准字H51022588 | 0.25g | Category A (甲) | XA10BAE021A017010102015 | NHSA |
| 吉林省东北亚药业股份有限公司 | 国药准字H22020508 | 0.25g | Category A (甲) | XA10BAE021A017010103405 | NHSA |
| 哈尔滨莱博通药业有限公司 | 国药准字H23021803 | 0.25g | Category A (甲) | XA10BAE021A017010103620 | NHSA |
| 福建省三明天泰制药有限公司 | 国药准字H35020639 | 0.25g | Category A (甲) | XA10BAE021A017010104819 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H35020664 | 0.25g | Category A (甲) | XA10BAE021A017010104864 | NHSA |
| 贵州圣济堂制药有限公司 | 国药准字H52020296 | 0.25g | Category A (甲) | XA10BAE021A017010105521 | NHSA |
| 双鹤天安药业(贵州)股份有限公司 | 国药准字H52020469 | 0.25g | Category A (甲) | XA10BAE021A017010105530 | NHSA |
| 北京市永康药业有限公司 | 国药准字H11020596 | 0.25g | Category A (甲) | XA10BAE021A017010200137 | NHSA |
| 华润双鹤药业股份有限公司 | 国药准字H11020541 | 0.25g | Category A (甲) | XA10BAE021A017010200144 | NHSA |
| 北京四环制药有限公司 | 国药准字H11020127 | 0.25g | Category A (甲) | XA10BAE021A017010200153 | NHSA |
| 广州白云山天心制药股份有限公司 | 国药准字H44023514 | 0.25g | Category A (甲) | XA10BAE021A017010200377 | NHSA |
| 成都川力制药有限公司 | 国药准字H51022588 | 0.25g | Category A (甲) | XA10BAE021A017010202015 | NHSA |
| 吉林省东北亚药业股份有限公司 | 国药准字H22020508 | 0.25g | Category A (甲) | XA10BAE021A017010203405 | NHSA |
| 哈尔滨莱博通药业有限公司 | 国药准字H23021803 | 0.25g | Category A (甲) | XA10BAE021A017010203620 | NHSA |
| 福建省三明天泰制药有限公司 | 国药准字H35020639 | 0.25g | Category A (甲) | XA10BAE021A017010204819 | NHSA |
| 双鹤天安药业(贵州)股份有限公司 | 国药准字H52020469 | 0.25g | Category A (甲) | XA10BAE021A017010205530 | NHSA |
| 北京市永康药业有限公司 | 国药准字H11020596 | 0.25g | Category A (甲) | XA10BAE021A017010300137 | NHSA |
| 北京四环制药有限公司 | 国药准字H11020127 | 0.25g | Category A (甲) | XA10BAE021A017010300153 | NHSA |
| 成都川力制药有限公司 | 国药准字H51022588 | 0.25g | Category A (甲) | XA10BAE021A017010302015 | NHSA |
| 福建省三明天泰制药有限公司 | 国药准字H35020639 | 0.25g | Category A (甲) | XA10BAE021A017010304819 | NHSA |
| 北京利龄恒泰药业有限公司 | 国药准字H11020957 | 0.25g | Category A (甲) | XA10BAE021A017020100088 | NHSA |
| 成都川力制药有限公司 | 国药准字H51022589 | 0.5g | Category A (甲) | XA10BAE021A017020102015 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H35020664 | 0.25g | Category A (甲) | XA10BAE021A017020104864 | NHSA |
| 北京利龄恒泰药业有限公司 | 国药准字H11020957 | 0.25g | Category A (甲) | XA10BAE021A017020200088 | NHSA |
| 成都川力制药有限公司 | 国药准字H51022589 | 0.5g | Category A (甲) | XA10BAE021A017020202015 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H35020664 | 0.25g | Category A (甲) | XA10BAE021A017020204864 | NHSA |
| 成都川力制药有限公司 | 国药准字H51022589 | 0.5g | Category A (甲) | XA10BAE021A017020302015 | NHSA |
| 成都川力制药有限公司 | 国药准字H51022589 | 0.5g | Category A (甲) | XA10BAE021A017020402015 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 4 filings and 3 distinct first applicants.
Generic 4
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 山东齐都药业有限公司 | CYHS2602136 | Generic | 2026/08/27 | Not stated by source | CDE |
| 山东齐都药业有限公司 | CYHS2602135 | Generic | 2026/08/27 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHS2601595 | Generic | 2026/07/06 | Not stated by source | CDE |
| 石家庄市华新药业有限责任公司 | CYHS2503174 | Generic | 2025/08/29 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 3 filings and 2 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 山东齐都药业有限公司 | CYHS2602136 | Generic | 2026/08/27 | Not stated by source | CDE |
| 山东齐都药业有限公司 | CYHS2602135 | Generic | 2026/08/27 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHS2601595 | Generic | 2026/07/06 | Not stated by source | CDE |
API registrations
Non-component matches: 40 companies with A status and 3 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 盐酸二甲双胍 | 河南优凯制药有限公司 | Y20250000327 | A | Exact ingredient | 2026/11/04 | CDE |
| 盐酸二甲双胍 | 山东鲁瑞药业有限公司 | Y20250000352 | A | Exact ingredient | 2026/09/21 | CDE |
| 盐酸二甲双胍 | 白云山东泰商丘药业有限公司 | Y20240000805 | A | Exact ingredient | 2026/03/15 | CDE |
| 盐酸二甲双胍 | 莱阳司邦得制药有限公司 | Y20240000473 | A | Exact ingredient | 2025/12/12 | CDE |
| 盐酸二甲双胍 | 吉林凯莱英医药化学有限公司 | Y20240000113 | A | Exact ingredient | 2025/11/10 | CDE |
| 盐酸二甲双胍 | Sohan Healthcare Private Limited | Y20220000895 | A | Exact ingredient | 2026/01/22 | CDE |
| 盐酸二甲双胍 | 河北天成药业股份有限公司 | Y20220001156 | A | Exact ingredient | 2025/02/20 | CDE |
| 盐酸二甲双胍 | 江苏德源药业股份有限公司 | Y20220000686 | A | Exact ingredient | 2025/05/27 | CDE |
| 盐酸二甲双胍 | 华东医药（西安）博华制药有限公司 | Y20220000357 | A | Exact ingredient | 2024/05/13 | CDE |
| 盐酸二甲双胍 | IOL Chemicals and Pharmaceuticals Ltd. | Y20210000679 | A | Exact ingredient | 2024/02/18 | CDE |
| 盐酸二甲双胍 | SMRUTHI ORGANICS LIMITED | Y20200001011 | I | Exact ingredient | 2021/05/25 | CDE |
| 盐酸二甲双胍 | 天方药业有限公司 | Y20200001441 | A | Exact ingredient | 2022/08/31 | CDE |
| 盐酸二甲双胍 | 山东寿光博康制药有限公司 | Y20200001309 | A | Exact ingredient | 2024/06/14 | CDE |
| 盐酸二甲双胍 | HARMAN FINOCHEM LIMITED | Y20200001045 | A | Exact ingredient | 2024/11/21 | CDE |
| 盐酸二甲双胍 | Harman Finochem Limited | Y20200000973 | A | Exact ingredient | 2023/03/24 | CDE |
| 盐酸二甲双胍 | 宁夏恒康科技有限公司 | Y20200001044 | A | Exact ingredient | 2024/01/17 | CDE |
| 盐酸二甲双胍 | Abhilasha Pharma Pvt. Ltd. | Y20190021198 | A | Exact ingredient | 2022/10/31 | CDE |
| 盐酸二甲双胍 | Exemed Pharmaceuticals | Y20200000139 | A | Exact ingredient | 2022/11/07 | CDE |
| 盐酸二甲双胍 | Laurus Labs Limited | Y20200000513 | A | Exact ingredient | 2024/08/09 | CDE |
| 盐酸二甲双胍 | Apitoria Pharma Private Limited | Y20200000422 | A | Exact ingredient | 2025/04/10 | CDE |
| 盐酸二甲双胍 | Wanbury Limited | Y20200000314 | A | Exact ingredient | 2022/10/14 | CDE |
| 盐酸二甲双胍 | MERCK SANTE SAS | Y20190009925 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 寿光富康制药有限公司 | Y20190009726 | A | Exact ingredient | 2026/01/24 | CDE |
| 盐酸二甲双胍 | 天津太平洋化学制药有限公司 | Y20190009517 | A | Exact ingredient | 2025/06/14 | CDE |
| 盐酸二甲双胍 | 山东科源制药股份有限公司 | Y20190009395 | A | Exact ingredient | 2026/07/07 | CDE |
| 盐酸二甲双胍 | Aarti Drugs Ltd. | Y20190009174 | A | Exact ingredient | 2025/08/06 | CDE |
| 盐酸二甲双胍 | 曲阜圣仁制药有限公司 | Y20190008915 | A | Exact ingredient | 2022/10/28 | CDE |
| 盐酸二甲双胍 | 石家庄市普力制药有限公司 | Y20190008451 | A | Exact ingredient | 2025/01/03 | CDE |
| 盐酸二甲双胍 | 江苏汉斯通药业有限公司 | Y20190007133 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 淮南舜隆制药有限公司 | Y20190006466 | A | Exact ingredient | 2026/06/23 | CDE |
| 盐酸二甲双胍 | 华润双鹤药业股份有限公司 | Y20190006308 | A | Exact ingredient | 2023/03/24 | CDE |
| 盐酸二甲双胍 | 江苏同禾药业有限公司 | Y20190006246 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 吉林金恒制药股份有限公司 | Y20190006023 | A | Exact ingredient | 2026/01/27 | CDE |
| 盐酸二甲双胍 | 好医生药业集团有限公司 | Y20190005982 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 吉林省四合药业科技有限公司 | Y20190005512 | A | Exact ingredient | 2025/01/04 | CDE |
| 盐酸二甲双胍 | null | Y20190004800 | A | Exact ingredient | 2024/06/06 | CDE |
| 盐酸二甲双胍 | 富祥（大连）制药有限公司 | Y20190004140 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | 丹东医创药业有限责任公司 | Y20190003827 | A | Exact ingredient | 2025/06/07 | CDE |
| 盐酸二甲双胍 | 天津中新药业集团股份有限公司新新制药厂 | Y20190002946 | A | Exact ingredient | 2023/03/24 | CDE |
| 盐酸二甲双胍 | null | Y20190002602 | A | Exact ingredient | 2024/10/24 | CDE |
| 盐酸二甲双胍 | FARMHISPANIA, S.A. | Y20190000147 | I | Exact ingredient | 2019/09/27 | CDE |
| 盐酸二甲双胍 | Vistin Pharma AS | Y20190000108 | A | Exact ingredient | 2026/09/24 | CDE |
| 盐酸二甲双胍 | MERCK SANTE S.A.S. | Y20180001691 | A | Exact ingredient | 2026/03/20 | CDE |
| 盐酸二甲双胍 | 天津太平洋化学制药有限公司 | Y20180000014 | I | Exact ingredient | 2018/10/22 | CDE |
| 盐酸二甲双胍 | 山东科源制药股份有限公司 | Y20180000016 | A | Exact ingredient | 2023/08/14 | CDE |
| 盐酸二甲双胍 | 寿光富康制药有限公司 | Y20180000778 | A | Exact ingredient | — | CDE |
| 盐酸二甲双胍 | MERCK SANTE SAS | Y20170002070 | A | Exact ingredient | 2024/11/17 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/08/27Accepted
-
2026/08/27Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Metformin Hydrochloride Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy